title: FDA approves antitoxin antibody.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D057134:Antibodies, Neutralizing / Q000009:adverse effects / Q000627:therapeutic use*; D000080908:Broadly Neutralizing Antibodies; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000517:prevention & control*; D017277:Drug Approval; D006801:Humans; D012008:Recurrence; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D000080908:Broadly Neutralizing Antibodies; C000613978:bezlotoxumab